If you made any changes in Pure these will be visible here soon.

Personal profile

Biography

Associate Professor Yoland Antill works as a Medical Oncologist and as a Cancer Genetics specialist within the public and private sector in Melbourne with over 20 years of experience in each discipline. Her working and research interests are in the management of Breast and Gynaecological cancers together with Hereditary Cancer Syndromes. She is the current chair of ANZGOG's Uterine Tumour working Group and a member of their Research Advisory Committee. Additionally she has advisory roles with Breast Cancer Network of Australia, Ovarian Cancer Australia as well as a number of Industry related boards.  Yoland is the lead investigator for a number of local and international research studies and is involved in the development and conduct of clinical and supportive care trials and has published extensively within peer review journals.

 

Associate Professor Yoland Antill, BMed FRACP MD

Medical Oncologist; Cabrini, Peninsula and Melbourne Health Services, VIC, Australia.

Adjunct Associate Professor, Monash University, VIC, Australia

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Research area keywords

  • Medical oncology
  • Hereditary cancer syndromes
  • Breast cancer
  • Gynaecological cancers

Network

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
  • The impact of coding germline variants on contralateral breast cancer risk and survival

    Morra, A., Mavaddat, N., Muranen, T. A., Ahearn, T. U., Allen, J., Andrulis, I. L., Auvinen, P., Becher, H., Behrens, S., Blomqvist, C., Bojesen, S. E., Bolla, M. K., Brauch, H., Camp, N. J., Carvalho, S., Castelao, J. E., Cessna, M. H., Chang-Claude, J., Chenevix-Trench, G., Czene, K., & 62 othersDecker, B., Dennis, J., Dörk, T., Dorling, L., Dunning, A. M., Ekici, A. B., Eriksson, M., Evans, D. G., Fasching, P. A., Figueroa, J. D., Flyger, H., Gago-Dominguez, M., García-Closas, M., Geurts-Giele, W. R. R., Giles, G. G., Guénel, P., Gündert, M., Hahnen, E., Hall, P., Hamann, U., Harrington, P. A., He, W., Heikkilä, P., Hooning, M. J., Hoppe, R., Howell, A., Humphreys, K., Jakubowska, A., Jung, A. Y., Keeman, R., Kristensen, V. N., Lubiński, J., Mannermaa, A., Manoochehri, M., Manoukian, S., Margolin, S., Mavroudis, D., Milne, R., Mulligan, A. M., Newman, W. G., Park-Simon, T. W., Peterlongo, P., Pharoah, P. D. P., Rhenius, V., Saloustros, E., Sawyer, E. J., Schmutzler, R. K., Shah, M., Spurdle, A. B., Tomlinson, I., Truong, T., van Veen, E. M., Vreeswijk, M. P. G., Wang, Q., Wendt, C., Yang, X. R., Nevanlinna, H., Devilee, P., Easton, D. F., Schmidt, M. K., NBCS Collaborators & kConFab Investigators, 2 Mar 2023, In: American Journal of Human Genetics. 110, 3, p. 475-486 12 p.

    Research output: Contribution to journalArticleResearchpeer-review

    Open Access
  • The role of depression and other psychological factors in work ability among breast cancer survivors in Australia

    Kim, S-Y., Kissane, D. W., Richardson, G., Senior, J., Morgan, J., Gregory, P., Birks, S., Ooi, C., Lipton, L., Antill, Y., Vereker, M., Michael, N. & Bobevski, I., Feb 2022, In: Psycho-Oncology. 31, 2, p. 167-175 9 p.

    Research output: Contribution to journalArticleResearchpeer-review

    8 Citations (Scopus)
  • CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers

    NBCS Collaborators, AOCS Group, ABCTB Investigators & kConFab Investigators, 16 Feb 2021, In: British Journal of Cancer. 124, 4, p. 842-854 13 p.

    Research output: Contribution to journalArticleResearchpeer-review

    Open Access
    5 Citations (Scopus)
  • Mendelian randomisation study of smoking exposure in relation to breast cancer risk

    Park, H. A., Neumeyer, S., Michailidou, K., Bolla, M. K., Wang, Q., Dennis, J., Ahearn, T. U., Andrulis, I. L., Anton-Culver, H., Antonenkova, N. N., Arndt, V., Aronson, K. J., Augustinsson, A., Baten, A., Beane Freeman, L. E., Becher, H., Beckmann, M. W., Behrens, S., Benitez, J., Bermisheva, M., & 106 othersBogdanova, N. V., Bojesen, S. E., Brauch, H., Brenner, H., Brucker, S. Y., Burwinkel, B., Campa, D., Canzian, F., Castelao, J. E., Chanock, S. J., Chenevix-Trench, G., Clarke, C., Conroy, D. M., Couch, F. J., Cox, A., Cross, S. S., Czene, K., Daly, M. B., Devilee, P., Dörk, T., dos-Santos-Silva, I., Dwek, M., Eccles, D. M., Eliassen, A. H., Engel, C., Eriksson, M., Evans, D. G., Fasching, P. A., Flyger, H., Fritschi, L., García-Closas, M., García-Sáenz, J. A., Gaudet, M. M., Giles, G. G., Glendon, G., Goldberg, M. S., Goldgar, D. E., González-Neira, A., Grip, M., Guénel, P., Hahnen, E., Haiman, C. A., Håkansson, N., Hall, P., Hamann, U., Han, S., Harkness, E. F., Hart, S. N., He, W., Heemskerk-Gerritsen, B. A. M., Hopper, J. L., Hunter, D. J., Jager, A., Jakubowska, A., John, E. M., Jung, A., Kaaks, R., Kapoor, P. M., Keeman, R., Khusnutdinova, E., Kitahara, C. M., Koppert, L. B., Koutros, S., Kristensen, V. N., Kurian, A. W., Lacey, J., Lambrechts, D., Le Marchand, L., Lo, W. Y., Lubiński, J., Mannermaa, A., Manoochehri, M., Margolin, S., Martinez, M. E., Mavroudis, D., Meindl, A., Menon, U., Milne, R. L., Muranen, T. A., Nevanlinna, H., Newman, W. G., Nordestgaard, B. G., Offit, K., Olshan, A. F., Olsson, H., Park-Simon, T. W., Peterlongo, P., Peto, J., Plaseska-Karanfilska, D., Presneau, N., Radice, P., Rennert, G., Rennert, H. S., Romero, A., Saloustros, E., Sawyer, E. J., Schmidt, M. K., Schmutzler, R. K., Schoemaker, M. J., Schwentner, L., Scott, C., Shah, M., Southey, M. C., NBCS Collaborators, ABCTB Investigators & kConFab Investigators, 12 Oct 2021, In: British Journal of Cancer. 125, 8, p. 1135-1145 11 p.

    Research output: Contribution to journalArticleResearchpeer-review

    Open Access
    3 Citations (Scopus)
  • Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses

    Kang, E. Y., Cheasley, D., LePage, C., Wakefield, M. J., da Cunha Torres, M., Rowley, S., Salazar, C., Xing, Z., Allan, P. E., Bowtell, D. D. L., Mes-Masson, A. M., Provencher, D. M., Rahimi, K., Kelemen, L. E., Fasching, P. A., Doherty, J. A., Goodman, M. T., Goode, E. L., Deen, S., Pharoah, P. D. P., & 25 othersBrenton, J. D., Sieh, W., Mateoiu, C., Sundfeldt, K., Cook, L. S., Le, N. D., Anglesio, M. S., Gilks, C. B., Huntsman, D. G., Kennedy, C. J., Traficante, N., DeFazio, A., Kaufmann, S. H., Churchman, M., Gourley, C., Stephens, A. N., Meagher, N. S., Ramus, S. J., Antill, Y. C., Campbell, I., Scott, C. L., Köbel, M., Gorringe, K. L., Australian Ovarian Cancer Study Group (AOCS) & GAMuT Collaborators, Jan 2021, In: Modern Pathology. 34, 1, p. 194-206 13 p.

    Research output: Contribution to journalArticleResearchpeer-review

    13 Citations (Scopus)